Problems with Yaz, Yasmin Result in 10.2% Decrease in Sales

Bayer has announced that concerns over blood clots from Yaz and Yasmin have contributed to a 10.2% drop in sales of their popular birth control pill. Awareness of the potential problems has increased in recent months, as a growing number of Yaz lawsuits and Yasmin lawsuits have been filed by women who allege that they suffered severe and life-threatening injuries while using the contraceptives. 

The statement came as part of Bayer’s quarterly report to investors on sales and earnings. The losses in the healthcare division were at odds with gains made in other parts of the company, which saw a 5.3% increase in sales overall for the first quarter of 2010.

“Demand for [the Yaz family of oral contraceptives] in the United States suffered particularly from the discussion surrounding the thrombosis risk of contraceptives containing drospirenone,” the company said in its report. “However, Bayer continues to believe that the risk profile is comparable to that of other combination oral contraceptives.”

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

Yaz and Yasmin are two similar birth control pills that are both manufactured by Bayer, containing drospirenone, a new “fourth” generation progestin. Drospirenone is only found in Yaz, Yasmin and a generic version sold under the name Ocella. Critics have pointed to this newer type of progestin as the likely cause of an increased risk of blood clots and other serious health problems with Yaz and Yasmin.

More than 1,100 lawsuits over Yaz, Yasmin and Ocella have been filed in the U.S. on behalf of women who allege that they suffered injuries such as a stroke, heart attack, pulmonary embolism, deep vein thrombosis, gallbladder disease and other complications. All federal Yaz and Yasmin cases are consolidated in an MDL, or multidistrict litigation, centralized in the Southern District of Illinois for pretrial litigation. There are also state level Yaz and Yasmin lawsuits consolidated in Pennsylvania and New Jersey courts.

At the same time women were abandoning Yaz and Yasmin birth control pills, sales of Bayer’s Mirena, a levonorgestral-based pill, skyrocketed more than 16%. Recent research has suggested that levonorgestral birth control pills may carry less risk of blood clots than Yaz, Yasmin and other oral contraceptives. One study published in the British Medical Journal in August found that birth control pills containing the progestin drospirenone increased the risk of blood clots in women 6.3 times over those not on birth control, while levonorgestrel-based pills only increased the risk about 4 times.

Last month, Bayer announced that new information would be added to the warning label about the risk of Yaz and Yasmin blood clot side effects compared to other birth control pills containing levonorgestrel.

1 Comments

  • colleenJune 30, 2010 at 1:27 pm

    my daughter started Yaz about 2 1/2 years ago, soon after she started she started feeling tired fatigued. He dr. sent her for blood work and they found her thyroid levels high. we went to an endo and she said it could have been a virus that attacted her thyroid and it is nothing to do with the birth control. she put her on synthroid for 3 months and her levels started to go to normal. dr told her[Show More]my daughter started Yaz about 2 1/2 years ago, soon after she started she started feeling tired fatigued. He dr. sent her for blood work and they found her thyroid levels high. we went to an endo and she said it could have been a virus that attacted her thyroid and it is nothing to do with the birth control. she put her on synthroid for 3 months and her levels started to go to normal. dr told her to come off the synthroid which she did. she started to feel find but in the mean time she had gotten mono (pretty severe) lost 22lbs from throwing up. she went off to school her bloodwork was checked every few weeks to make sure her liver functions were back to normal. which they were. dr always had her tsh checked and looking at the levels they slowly rised until the spring of the following year they reached 5.8 went to another edno and she prescribed synthroid again as well as b12. my daughter started feeling a little better but not 100%. (she is a runner, athlete and out going) she since just lays around mood swings, depression, sad, crying weight gain and they found noduals on her thryoid. I told her to go to the obgyn and they said Yaz has nothing to do with these problems. my girlfrieds dr said to her daughter to come off Yaz right away there are too many dangerous side effects. I told my daughter to stop Yaz and we will find another dr. I strongly beleive her problems stem from this Yaz. I don't have any proof except a mother knows her children. I hope there is some evidence of this since I dont know what to do anymore. I need to help her and I feel I cannot do this without some direction.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure
Bard Settlement Reached To Resolve Hernia Mesh Lawsuits, With “Multi-Year” Payout Structure (Posted today)

Lawyers have reached a confidential settlement agreement to resolve tens of thousands of Bard hernia mesh lawsuits after six years of litigation, but individuals must still agree to participate and settle their claims.

Class Action Claims Over Hair Relaxer Risks Cleared To Move Forward by MDL Judge
Class Action Claims Over Hair Relaxer Risks Cleared To Move Forward by MDL Judge (Posted yesterday)

Court rejected a motion to dismiss the hair relaxer class actions lawsuits, which seek economic damages for consumers exposed to toxic chemicals in the products, which are now known to increase the risk of uterine cancer, ovarian cancer and other injuries.